Research Tax Credit agreement / CIR

Research Tax Credit agreement / CIR

Imavita has Research Tax Credit agreement / CIR (“Crédit Impôt Recherche“) for years 2016 to 2020 (obtained on April 22th 2016 / download pdf file of Research Tax Credit Accreditation).

This agreement, obtained from the french authorities, permits to the clients working with Imavita to refund R&D spendings to their corporate taxes.

See the following links for more informations on CIR / Research Tax Credit: MESR (Ministère de l’Enseignement Supérieur et de la Recherche)

Summary on Research Tax Credit

All companies incurring R&D expenses are eligible to receive France’s research tax credit, regardless of their size, business sector and nationality.

R&D Imavita

The tax credit covers 30% of all R&D expenses and covers all R&D spending: Salaries, social security contributions, amortization and depreciation allowances, operating costs, subcontracting, patents and monitoring.
The scope of SME spending eligible for the research tax credit has been extended as of 2013 to cover innovation expenses arising from designing prototypes, as well as pilot plants for new products. These expenses are now included in the research tax credit base, at a rate of 20%.
For income tax purposes, the definition of a qualified activity for the Research & Experimentation (R&E) Tax Credit or the research and development (R&D) Tax Credit includes not only the development of new products, but also improvements to products, processes, techniques, formulas, patents, and software applications.

Categories: News

About the Author

Eric Lacoste ()

Veterinary with experience in biomarkers / imaging of preclinical species Founder of the company Imavita

Website: https://imavita.com